20.06.2023 17:46:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, DICE

NEW YORK, June 20, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Chinook Therapeutics, Inc. (NASDAQ: KDNY)'s sale to Novartis AG for $40.00 per share in cash. Chinook shareholders will also receive contingent value rights providing for payment of up to $4.00 per share upon the achievement of certain future regulatory milestones with respect to Chinook's lead product candidate, atrasentan. If you are a Chinook shareholder, click here to learn more about your rights and options.

Eneti Inc. (NYSE: NETI)'s sale to Cadeler A/S for 3.409 Cadeler shares for each Eneti share. Upon completion of the transaction, Eneti shareholders will own approximately 40% of the combined company. If you are an Eneti shareholder, click here to learn more about your rights and options.

DICE Therapeutics, Inc. (NASDAQ: DICE)'s sale to Eli Lilly and Company for $48.00 per share in cash. If you are a DICE shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-kdny-neti-dice-301855374.html

SOURCE Halper Sadeh LLP

Nachrichten zu Chinook Therapeutics Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Chinook Therapeutics Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!